194 related articles for article (PubMed ID: 9407986)
1. Prognostic relevance of occult tumor cells in lymph nodes of colorectal carcinomas: an immunohistochemical study.
Broll R; Schauer V; Schimmelpenning H; Strik M; Woltmann A; Best R; Bruch HP; Duchrow M
Dis Colon Rectum; 1997 Dec; 40(12):1465-71. PubMed ID: 9407986
[TBL] [Abstract][Full Text] [Related]
2. Prognostic evaluation and review of immunohistochemically detected disseminated tumor cells in peritumoral lymph nodes of patients with pN0 colorectal cancer.
Rosenberg R; Friederichs J; Gertler R; Hoos A; Mueller J; Nahrig J; Nekarda H; Siewert JR
Int J Colorectal Dis; 2004 Sep; 19(5):430-7. PubMed ID: 14716495
[TBL] [Abstract][Full Text] [Related]
3. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival.
Greenson JK; Isenhart CE; Rice R; Mojzisik C; Houchens D; Martin EW
Cancer; 1994 Feb; 73(3):563-9. PubMed ID: 7507795
[TBL] [Abstract][Full Text] [Related]
4. Occult lymph node metastases as a predictor of tumor relapse in patients with node-negative esophageal carcinoma.
Vazquez-Sequeiros E; Wang L; Burgart L; Harmsen W; Zinsmeister A; Allen M; Jondal M; Wiersema M
Gastroenterology; 2002 Jun; 122(7):1815-21. PubMed ID: 12055589
[TBL] [Abstract][Full Text] [Related]
5. Morphological and immunohistochemical characterization of isolated tumor cells by p53 status in gastrointestinal tumors.
Milsmann C; Füzesi L; Heinmöller E; Krause P; Werner C; Becker H; Horstmann O
Langenbecks Arch Surg; 2008 Jan; 393(1):49-58. PubMed ID: 17876601
[TBL] [Abstract][Full Text] [Related]
6. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in "node-negative" colorectal cancer.
Sasaki M; Watanabe H; Jass JR; Ajioka Y; Kobayashi M; Matsuda K; Hatakeyama K
J Gastroenterol; 1997 Dec; 32(6):758-64. PubMed ID: 9430013
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of occult lymph node metastases in node-negative breast cancer.
Clare SE; Sener SF; Wilkens W; Goldschmidt R; Merkel D; Winchester DJ
Ann Surg Oncol; 1997 Sep; 4(6):447-51. PubMed ID: 9309332
[TBL] [Abstract][Full Text] [Related]
8. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.
Reed W; Bøhler PJ; Sandstad B; Nesland JM
Breast J; 2004; 10(3):174-80. PubMed ID: 15125740
[TBL] [Abstract][Full Text] [Related]
9. Incidence and prognostic significance of occult tumor cells in lymph nodes from patients with stage IIA colorectal carcinoma.
Messerini L; Cianchi F; Cortesini C; Comin CE
Hum Pathol; 2006 Oct; 37(10):1259-67. PubMed ID: 16949928
[TBL] [Abstract][Full Text] [Related]
10. The impact of the number of occult metastatic lymph nodes on postoperative relapse of resectable esophageal cancer.
Morimoto J; Tanaka H; Ohira M; Kubo N; Muguruma K; Sakurai K; Yamashita Y; Maeda K; Sawada T; Hirakawa K
Dis Esophagus; 2014 Jan; 27(1):63-71. PubMed ID: 23480452
[TBL] [Abstract][Full Text] [Related]
11. Incidence and prognostic implications of isolated tumor cells in lymph nodes from patients with Dukes B colorectal carcinoma.
Choi HJ; Choi YY; Hong SH
Dis Colon Rectum; 2002 Jun; 45(6):750-5; discussion755-6. PubMed ID: 12072625
[TBL] [Abstract][Full Text] [Related]
12. [Significance of occult lymphatic tumor spread in pancreatic cancer].
Milsmann C; Füzesi L; Werner C; Becker H; Horstmann O
Chirurg; 2005 Nov; 76(11):1064-72. PubMed ID: 15971035
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer.
Passlick B; Izbicki JR; Kubuschok B; Nathrath W; Thetter O; Pichlmeier U; Schweiberer L; Riethmüller G; Pantel K
J Clin Oncol; 1994 Sep; 12(9):1827-32. PubMed ID: 8083707
[TBL] [Abstract][Full Text] [Related]
14. Micrometastasis in regional lymph nodes of extirpated colorectal carcinoma: immunohistochemical study using anti-cytokeratin antibodies AE1/AE3.
Palma RT; Waisberg J; Bromberg SH; Simão AB; Godoy AC
Colorectal Dis; 2003 Mar; 5(2):164-8. PubMed ID: 12780907
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of lymphatic invasion of colorectal cancer: a single-center analysis of 1,616 patients over 24 years.
Akagi Y; Adachi Y; Ohchi T; Kinugasa T; Shirouzu K
Anticancer Res; 2013 Jul; 33(7):2965-70. PubMed ID: 23780987
[TBL] [Abstract][Full Text] [Related]
16. Significance of the immunohistochemical detection of lymph node micrometastases in stage II colorectal carcinoma.
García-Sáenz JA; Sáenz MC; González L; Pérez-Segura P; Puente J; López-Tarruella S; Sastre J; Casado A; López-Asenjo JG; Díaz-Rubio E
Clin Transl Oncol; 2006 Sep; 8(9):676-80. PubMed ID: 17005470
[TBL] [Abstract][Full Text] [Related]
17. Isolated tumor cells in lymph nodes are not a prognostic marker for patients with stage I and stage II colorectal cancer.
Lee MR; Hong CW; Yoon SN; Lim SB; Park KJ; Lee MJ; Kim WH; Park JG
J Surg Oncol; 2006 Jan; 93(1):13-8; discussion 18-9. PubMed ID: 16353185
[TBL] [Abstract][Full Text] [Related]
18. Occult disseminated tumor cells in lymph nodes of patients with gastric carcinoma. A critical appraisal of assessment and relevance.
Scheunemann P; Stoecklein NH; Hermann K; Rehders A; Eisenberger CF; Knoefel WT; Hosch SB
Langenbecks Arch Surg; 2009 Jan; 394(1):105-13. PubMed ID: 18626657
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemically detected micrometastases in peribronchial and mediastinal lymph nodes from patients with T1, N0, M0 pulmonary adenocarcinomas.
Goldstein NS; Mani A; Chmielewski G; Welsh R; Pursel S
Am J Surg Pathol; 2000 Feb; 24(2):274-9. PubMed ID: 10680895
[TBL] [Abstract][Full Text] [Related]
20. Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small-cell lung carcinoma.
Chen ZL; Perez S; Holmes EC; Wang HJ; Coulson WF; Wen DR; Cochran AJ
J Natl Cancer Inst; 1993 Mar; 85(6):493-8. PubMed ID: 7680382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
